NCT03197506 2026-03-25Pembrolizumab and Standard Therapy in Treating Patients With GlioblastomaMayo ClinicPhase 2 Active not recruiting52 enrolled 19 charts
NCT02337686 2025-08-15Pembrolizumab in Treating Patients With Recurrent GlioblastomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting18 enrolled 12 charts